Scrotel-MT 25 Tablet ER
Marketer
Chinar Therapeutics Pvt.&Ltd.
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Scrotel-MT 25 Tablet ER
Hyperten-25 Extended Release tablets manage hypertension, reducing the risk of heart attacks and strokes. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking Hyperten-25 with food daily, as prescribed. Continue treatment as directed; even asymptomatic hypertension requires ongoing management. Discontinuing the medication can worsen your condition. Lifestyle changes including exercise, weight management, and a healthy diet are also crucial. Strictly follow your physician's instructions. Potential side effects include headache, weakness, lightheadedness, hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach upset, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor about pre-existing liver or kidney disease, and if you are pregnant or breastfeeding. Always disclose all other medications, especially those for hypertension or heart conditions.
Uses of Scrotel-MT 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Scrotel-MT 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Scrotel-MT 25 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Scrotel-MT 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Scrotel-MT 25 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Scrotel-MT 25 Extended-Release Tablet with food.
How Scrotel-MT 25 Tablet ER works:
Each Scrotel-MT 25 Extended-Release tablet contains Telmisartan and Metoprolol Succinate, two agents that work together to reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Scrotel-MT 25 Tablet ER use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Scrotel-MT 25 Extended-Release tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it when benefits outweigh potential harm. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Scrotel-MT 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Scrotel-MT 25 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Scrotel-MT 25 tablets pose no known safety concerns for individuals with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with hepatic impairment should use Scrotel-MT 25 Tablet ER cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Scrotel-MT 25 Tablet ER :
Should you forget to take your Scrotel-MT 25 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Scrotel-MT 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Heart |
3,018 People bought this recently